Tectonic Therapeutic, Inc.TECXNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +297.53% | +359.67% | +26.78% | +26.91% | +23.86% |
| Weighted Average Shares Diluted Growth | +297.53% | +359.67% | +26.78% | +26.91% | +23.86% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +288.09% | +240.92% | +52.29% | +64.18% | +70.72% |
| Book Value per Share Growth | +0.00% | -26.28% | +34.54% | +40.19% | +44.14% |
| Debt Growth | -23.95% | -36.19% | -43.58% | -58.51% | -61.37% |
| R&D Expense Growth | +27.31% | +20.50% | +142.93% | +18.23% | +78.47% |
| SG&A Expenses Growth | +121.59% | +144.74% | +18.40% | -6.71% | +7.03% |